Literature DB >> 406327

Enzyme-immunoassay in the detection of hepatitis B surface antigen.

P Ukkonen, V Koistinen, K Penttinen.   

Abstract

A new enzyme-immunoassay (EIA, Hepanostika Microelisa System) for the detection of hepatitis B surface antigen was evaluated against other methods, namely complement fixation, Hepanosticon, AusRIA II and Finnish Red Cross Radioimmunoassay (FRC-RIA). EIA detected the greatest number of positive samples in a serum panel consisting of 142 sera from clinical hepatitis patients. FRC-RIA was the most sensitive method for subtype ad, while EIA detected the ay specimen at the highest dilution. None of the test systems gave the 'optimal' result in the screening test, and it is proposed that a separate procedure for each antigen subtype should be carried out to detect the greatest number of positive samples.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 406327     DOI: 10.1016/0022-1759(77)90096-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Comparison of radioimmunoassay and enzyme immunoassay for detecting hepatitis B surface antigen in serum from freshly donated blood and selected blood products.

Authors:  R Hopkins; S Ross; T Jordan; A D Watt
Journal:  J Clin Pathol       Date:  1978-10       Impact factor: 3.411

2.  Comparison of a monoclonal antibody with a polyclonal serum in an enzyme-linked immunosorbent assay for detecting adenovirus.

Authors:  L J Anderson; E Godfrey; K McIntosh; J C Hierholzer
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

3.  Improved economics of HBsAg screening with commercial radioimmunoassay reagents.

Authors:  R Hopkins; S Ross; T Jordan; A D Watt
Journal:  J Clin Pathol       Date:  1980-01       Impact factor: 3.411

Review 4.  Enzyme immunoassays with special reference to ELISA techniques.

Authors:  A Voller; A Bartlett; D E Bidwell
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.